Insulin detemir
انسولین دتمیر
🍽️ Alimentary Tract And MetabolismLong-acting basal insulin
Market / country: 🇺🇸 USA
Levemir (US)
🧮 Dose calculator
Type 2 diabetes mellitus · Regimen source: FDA Levemir · 2.3
- • Once with the evening meal or at bedtime, or split twice daily. Titrate by glucose. FDA Levemir · 2.2FDA Levemir · 2.3
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ During hypoglycaemia; hypersensitivity to insulin detemir. FDA Levemir · 4
Warnings
- • Hypoglycaemia; hypokalaemia; never share pens. FDA Levemir · 5
Formulations
- 100 units/mL FlexPen or vial — injection 🇺🇸 USA FDA Levemir · 3
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Levemir · 8.1
“Risk Summary Available data from published studies and postmarketing case reports with LEVEMIR use in pregnant women have not identified a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Levemir · 8.2
“Risk Summary Available data from published literature demonstrate that exogenous human insulin products, including biosynthetic insulins such as insulin detemir, are transferred into human milk.”
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Levemir · 8.4
“The safety and effectiveness of LEVEMIR to improve glycemic control in pediatric patients with diabetes mellitus have been established.”
- 👴 Older adultsNo specific problem stated
Label: no specific difference or dose adjustment stated for older adults. FDA Levemir · 8.5
“No overall differences in safety or effectiveness were observed between these patients and younger patients, but small sample sizes limits conclusions.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)BLA021536
- DailyMed (FDA label)FDA Levemir
- MedlinePlus (NIH)Insulin Detemir (rDNA Origin) Injection
- WHO ATC/DDDA10AE05
- Darooyab (Iran)❌ None
🇮🇷 Not found in Iran list Darooyab · search
Darooyab lists no registered dosage form or brand for this drug. This does not prove it is unavailable.
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Levemir · 3FDA Levemir · 2.3FDA Levemir · 2.2FDA Levemir · 4FDA Levemir · 5FDA Levemir · SPL approval / marketing categoryFDA Levemir · 8.1FDA Levemir · 8.2FDA Levemir · 8.4FDA Levemir · 8.5
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · search
- Clinical review⚠ Unverified